Portfolio company
Veriskin
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Veriskin develops a handheld medical device using artificial intelligence to help primary care providers non-invasively detect skin cancer during routine physical examinations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Dermus
Dermus develops handheld high-frequency ultrasound devices and AI-powered cloud software for dermatologists to diagnose and monitor skin conditions such as cancer and inflammation.
SkinScreener
This company develops a mobile application that uses artificial intelligence to assess skin cancer risk from photos for individual consumers and corporate employees.
DermaScan
DermaScan operates medical centres providing digital body mapping and artificial intelligence tools for early skin cancer detection to patients and healthcare providers.
Damae Medical
This company develops optical imaging devices and artificial intelligence software for dermatologists to provide non-invasive diagnosis and management of skin cancers.
Squaremind
This company develops a robotic skin scanning device and artificial intelligence platform to assist physicians in detecting cancer through full-body dermoscopy.
Dermie AI
This company develops an artificial intelligence mobile application that enables consumers to track and monitor skin health changes using computer vision technology.
Bdetect
Bdetect develops multispectral imaging devices for non-invasive skin cancer screening, serving medical professionals and healthcare facilities.
Skin Analytics
This company develops artificial intelligence software for skin cancer screening to support national health services and private medical insurers with patient triage.
